Lower-Risk MDS

Case presentation

BMBx

  • 35% cellularity
  • blasts 1%
  • dysplasia in 15% of erythroid precursors (megaloblastic erythroblasts, basophilic stippling, cytoplasmic vacuolation)
  • no ringed sideroblasts
  • del(5q)
  • NGS pending
5 / 24